CD22-CAR T Cells

· Stanford University

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for CD22-CAR T Cells, covering 2019-12-23 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies [Phase 1]